1 Medical Study Program, Faculty of Medicine, Universitas Airlangga, Indonesia.
2 Department of Neurology, Faculty of Medicine, Universitas Airlangga; Airlangga University Hospital, Indonesia.
3 Department of Clinical Pharmacology, Faculty of Medicine, Universitas Airlangga, Indonesia.
* Corresponding Author
Received on 16 September 2026; revised on 28 October 2026; accepted on 30 October 2026
Parkinson’s Disease (PD) is a chronic neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons. Recent scientific paradigms have shifted focus from the central nervous system to the bidirectional communication between the gastrointestinal tract and the brain, known as the gut-brain axis. This literature review aims to explore the mechanisms by which intestinal microbiota imbalance (dysbiosis) and gut inflammation contribute to PD pathogenesis through the spread of misfolded alpha-synuclein protein. Key factors such as immune responses, intestinal permeability, and microbial metabolites are identified as crucial elements in disease progression. A deeper understanding of this axis highlights the potential for novel microbiota-based therapeutic interventions to improve patient prognosis and mitigate the global burden of Parkinson's Disease.
Parkinson’s Disease (Pd), Gut-Brain Axis, Gut Microbiota, Alpha-Synuclein, Neuroinflammation.
Preview Article PDF
Rahardian Pratama, Priya Nugraha and Sri Purwaningsih. THE ROLE OF THE GUT-BRAIN AXIS IN THE PATHOPHYSIOLOGY OF PARKINSON’S DISEASE: A CURRENT LITERATURE REVIEW. Magna Scientia Advanced Research and Review, 2026, 18(02), 007–010. Article DOI: https://doi.org/10.30574/msarr.2026.18.2.0216